Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2022-11-02 00:00:00 ET · period of report 2022-10-31 · accession 0001209191-22-055389 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-02 | 2022-10-31 | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale | $114.12 | -1,295 | 2,919 | -31% | -$147.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-31 | S | D | 1,295 | $114.12 | 2,919 | D | — | — |